Search results
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 20 hours agoWhile it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal ...
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga via Yahoo Finance· 4 days agoPfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by...
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga· 4 days agoPfizer Inc PFE is looking to build on the success of its COVID-19 vaccine rollout by introducing a...
Genetics Played a Role in Blood Clots Linked to COVID-19 Shots
Time Magazine· 1 day agoAdenovirus-based vaccines, like the J&J and AstraZeneca shots that were later pulled from the...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoCAR-T drugs are developed using a patient's own immune cells. Promisingly, Pfizer said in February...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 1 day agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock | The Motley...
The Motley Fool· 4 days agoPfizer (PFE -0.21%) stock has struggled over the past year, losing around 28% of its value. Its...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots |...
The State· 23 hours agoSince last week, hundreds of social media posts and news stories have claimed that AstraZeneca is removing its COVID vaccine from the market after admitting it caused blood ...
GSK raises $1.5 billion from sale of remaining Haleon stake
Reuters via Yahoo Finance· 9 hours agoThe sale will allow GSK to sharpen its focus on vaccines, cancer and infectious diseases, which are...